Tocilizumab in COVID-19: Is the Temptation Worthwhile?

Indian J Crit Care Med. 2021 Mar;25(3):247-248. doi: 10.5005/jp-journals-10071-23750.

Authors

Sachin Gupta¹, Deeksha S Tomar¹

Affiliation

¹ Department of Critical Care Medicine, Narayana Superspeciality Hospital, Gurugram, Haryana, India.

Abstract

How to cite this article: Gupta S, Tomar DS. Tocilizumab in COVID-19: Is the Temptation Worthwhile? Indian J Crit Care Med 2021;25(3): 247-248.

Keywords: Cytokine storm; IL-6 blockade; Tocilizumab.

Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd.

Publication types

Editorial